These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23869885)

  • 1. Does aliskiren protect the kidney following ischemia reperfusion injury?
    Hammad FT; Al-Salam S; Lubbad L
    Physiol Res; 2013; 62(6):681-90. PubMed ID: 23869885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotection by Direct Renin Inhibition: A Systematic Review and Meta- Analysis.
    Louvis N; Coulson J
    Curr Vasc Pharmacol; 2018 Jan; 16(2):157-167. PubMed ID: 28464775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.
    Ziypak T; Halici Z; Alkan E; Akpinar E; Polat B; Adanur S; Cadirci E; Ferah I; Bayir Y; Karakus E; Mercantepe T
    Ren Fail; 2015 Mar; 37(2):343-54. PubMed ID: 25524622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren - a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.
    Bayir Y; Cadirci E; Polat B; Kilic Baygutalp N; Albayrak A; Karakus E; Un H; Keles MS; Kocak Ozgeris FB; Toktay E; Karaca M; Halici Z
    Gynecol Endocrinol; 2016 Aug; 32(8):675-683. PubMed ID: 26939623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury.
    Tenkumo K; Hirooka K; Sherajee SJ; Nakamura T; Itano T; Nitta E; Fujita T; Nishiyama A; Shiraga F
    Exp Eye Res; 2014 May; 122():110-8. PubMed ID: 24709336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin provides incomplete protection of the kidney in ischemia reperfusion injury.
    Hammad FT; Al-Salam S; Lubbad L
    Physiol Res; 2012; 61(5):503-11. PubMed ID: 22881234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy.
    Hammad FT; Al-Salam S; Yuvaraju P; Lubbad L
    Drug Dev Res; 2018 Nov; 79(7):315-323. PubMed ID: 30291750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease.
    Lizakowski S; Tylicki L; Rutkowski P; Renke M; Sulikowska B; Heleniak Z; Donderski R; Bednarski R; Przybylska M; Manitius J; Rutkowski B
    Pol Arch Med Wewn; 2013; 123(5):221-7. PubMed ID: 23615633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats.
    Gandhi S; Srinivasan BP; Akarte AS
    Eur J Pharm Sci; 2012 May; 46(1-2):32-42. PubMed ID: 22349361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of aliskiren in Japanese chronic kidney disease patients with hypertension.
    Sakai Y; Otsuka T; Ohno D; Murasawa T; Sato N; Mizuno K
    Ren Fail; 2012; 34(4):442-7. PubMed ID: 22260457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
    Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
    J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aliskiren on the renal dysfunction following unilateral ureteral obstruction in the rat.
    Hammad FT; Lubbad L
    Int J Physiol Pathophysiol Pharmacol; 2016; 8(2):70-7. PubMed ID: 27570581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia-reperfusion injury in the rat.
    Hammad FT; Al-Salam S; AlZaabi SS; Alfalasi MM; Hammad AF; Yasin J; Lubbad L
    Physiol Rep; 2021 Mar; 9(6):e14723. PubMed ID: 33719192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.
    Sato A; Piao H; Nozawa Y; Morioka T; Kawachi H; Oite T
    Clin Exp Nephrol; 2012 Aug; 16(4):539-48. PubMed ID: 22327564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats.
    Wang Z; Liu Y; Han Y; Guan W; Kou X; Fu J; Yang D; Ren H; He D; Zhou L; Zeng C
    Eur J Pharmacol; 2013 Oct; 718(1-3):160-6. PubMed ID: 24041923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney.
    Essam M; Barakat N; Elkashef A; Awadalla A; Behery AE; Abdel-Maboud M
    Life Sci; 2021 Jan; 265():118811. PubMed ID: 33259867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
    Feldman DL
    Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.